Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (161-170 of 292) with videos related to

Pageof 30
Sort By:
European Journal of Heart Failure|November 20, 2022
Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathyMatthew T Wheeler, Daniel Jacoby, Perry M Elliott, et al.
Heart (British Cardiac Society)|October 30, 2014
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathyLuis R Lopes, Petros Syrris, Oliver P Guttmann, et al.
Molecular Genetics and Metabolism|November 11, 2018
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of expertsDominique P Germain, Michael Arad, Alessandro Burlina, et al.
JACC. Cardiovascular Imaging|December 4, 2025
Right Ventricular Outflow Tract Diameter for Event Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: Incremental Value Over Echocardiographic Free-Wall StrainThierry G Donati, Francesca Ortelli, Monika Hebeisen, et al.
Journal of Cardiac Failure|September 30, 2024
The Kansas City Cardiomyopathy Questionnaire in Relation to New York Heart Association ClassCharles F Sherrod, John A Spertus, Kensey L Gosch, et al.
Circulation|January 18, 2006
Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathyPetros Syrris, Deirdre Ward, Angeliki Asimaki, et al.
International Journal of Molecular Sciences|February 28, 2020
A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy CohortMaria Bueno Marinas, Rudy Celeghin, Marco Cason, et al.
Circulation. Arrhythmia and Electrophysiology|May 25, 2016
Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic CardiomyopathyConstantinos O'Mahony, Fatima Jichi, Lorenzo Monserrat, et al.
European Heart Journal|December 25, 2004
Natural history and familial characteristics of isolated left ventricular non-compactionRoss T Murphy, Rajesh Thaman, Juan Gimeno Blanes, et al.
Stem Cell Research|October 24, 2024
Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic CardiomyopathyJoanna Jager, Marta Ribeiro, Marta Furtado, et al.
Pageof 30

Showing results (161-170 of 292) with videos related to

Sort By:
Pageof 30
European Journal of Heart Failure|November 20, 2022
Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathyMatthew T Wheeler, Daniel Jacoby, Perry M Elliott, et al.
Heart (British Cardiac Society)|October 30, 2014
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathyLuis R Lopes, Petros Syrris, Oliver P Guttmann, et al.
Molecular Genetics and Metabolism|November 11, 2018
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of expertsDominique P Germain, Michael Arad, Alessandro Burlina, et al.
JACC. Cardiovascular Imaging|December 4, 2025
Right Ventricular Outflow Tract Diameter for Event Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: Incremental Value Over Echocardiographic Free-Wall StrainThierry G Donati, Francesca Ortelli, Monika Hebeisen, et al.
Journal of Cardiac Failure|September 30, 2024
The Kansas City Cardiomyopathy Questionnaire in Relation to New York Heart Association ClassCharles F Sherrod, John A Spertus, Kensey L Gosch, et al.
Circulation|January 18, 2006
Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathyPetros Syrris, Deirdre Ward, Angeliki Asimaki, et al.
International Journal of Molecular Sciences|February 28, 2020
A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy CohortMaria Bueno Marinas, Rudy Celeghin, Marco Cason, et al.
Circulation. Arrhythmia and Electrophysiology|May 25, 2016
Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic CardiomyopathyConstantinos O'Mahony, Fatima Jichi, Lorenzo Monserrat, et al.
European Heart Journal|December 25, 2004
Natural history and familial characteristics of isolated left ventricular non-compactionRoss T Murphy, Rajesh Thaman, Juan Gimeno Blanes, et al.
Stem Cell Research|October 24, 2024
Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic CardiomyopathyJoanna Jager, Marta Ribeiro, Marta Furtado, et al.
Pageof 30